search
Back to results

Myocardial Protection and Clinical Outcome in Patients Undergoing Tetralogy of Fallot Repair : A Randomized Study of Two Different Cardioplegia Technique (TOF)

Primary Purpose

Myocardial Protection in TOF Repair

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
blood cardioplegia
del nido cardioplegia
Sponsored by
SUNDER LAL NEGI
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Myocardial Protection in TOF Repair focused on measuring tetralogy of fallot, cardioplegia

Eligibility Criteria

1 Year - 50 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Tetralogy of fallot

Exclusion Criteria:

  • TOF with absent pulmonary valve , TOF with pulmonary atresia

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    blood cardioplegia

    del nido cardioplegia

    Arm Description

    these patients received blood cardioplegia

    these patients received del nido cardioplegia

    Outcomes

    Primary Outcome Measures

    inotropic score
    Creatine kinase MB level baseline preoperative and postoperative 0, 6, 24, and 72 hours
    resumption of spontaneous rhythm after aortic cross clamp off

    Secondary Outcome Measures

    duration of mechanical ventilation in hours
    ICU stay
    hospital mortality
    echocardiographic assessment

    Full Information

    First Posted
    December 24, 2015
    Last Updated
    December 31, 2015
    Sponsor
    SUNDER LAL NEGI
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02646254
    Brief Title
    Myocardial Protection and Clinical Outcome in Patients Undergoing Tetralogy of Fallot Repair : A Randomized Study of Two Different Cardioplegia Technique
    Acronym
    TOF
    Official Title
    MYOCARDIAL PROTECTION AND CLINICAL OUTCOME IN PATIENTS UNDERGOING TETRALOGY OF FALLOT REPAIR: A RANDOMIZED STUDY OF TWO CARDIOPLEGIC TECHNIQUES
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2015
    Overall Recruitment Status
    Completed
    Study Start Date
    June 2014 (undefined)
    Primary Completion Date
    August 2015 (Actual)
    Study Completion Date
    October 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    SUNDER LAL NEGI

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Myocardial protection and clinical outcome in patients Undergoing tetralogy of fallot repair: a randomized study of Two cardioplegic techniques.
    Detailed Description
    Del Nido cardioplegia has not been used for myocardial protection and clinical outcome in patients undergoing tetralogy of Fallot repair, so the investigators hypothesized that a del Nido cardioplegia technique may be beneficial in the pediatric patients undergoing tetralogy of fallot repair.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Myocardial Protection in TOF Repair
    Keywords
    tetralogy of fallot, cardioplegia

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    Investigator
    Allocation
    Randomized
    Enrollment
    56 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    blood cardioplegia
    Arm Type
    Active Comparator
    Arm Description
    these patients received blood cardioplegia
    Arm Title
    del nido cardioplegia
    Arm Type
    Active Comparator
    Arm Description
    these patients received del nido cardioplegia
    Intervention Type
    Other
    Intervention Name(s)
    blood cardioplegia
    Intervention Type
    Other
    Intervention Name(s)
    del nido cardioplegia
    Primary Outcome Measure Information:
    Title
    inotropic score
    Time Frame
    First 24 hours
    Title
    Creatine kinase MB level baseline preoperative and postoperative 0, 6, 24, and 72 hours
    Time Frame
    72hrs
    Title
    resumption of spontaneous rhythm after aortic cross clamp off
    Time Frame
    10 minutes
    Secondary Outcome Measure Information:
    Title
    duration of mechanical ventilation in hours
    Time Frame
    48 hours
    Title
    ICU stay
    Time Frame
    7 days
    Title
    hospital mortality
    Time Frame
    30 days
    Title
    echocardiographic assessment
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    1 Year
    Maximum Age & Unit of Time
    50 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Tetralogy of fallot Exclusion Criteria: TOF with absent pulmonary valve , TOF with pulmonary atresia

    12. IPD Sharing Statement

    Learn more about this trial

    Myocardial Protection and Clinical Outcome in Patients Undergoing Tetralogy of Fallot Repair : A Randomized Study of Two Different Cardioplegia Technique

    We'll reach out to this number within 24 hrs